Skip to main content
SpringerLink
Log in

Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss

  • Chapter
  • First Online:
Polycystic Ovary Syndrome

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-aged women. It is typically characterized by hyperandrogenism, chronic anovulation, and the presence of polycystic ovaries. Dermatologic manifestations commonly encountered in women with PCOS include hirsutism, acne vulgaris, and androgenic alopecia or female hair loss. This chapter reviews the treatments for these clinical manifestations that are attributed to androgen excess in women with PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.e25.

    Article  PubMed  Google Scholar 

  2. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.

    Article  Google Scholar 

  3. Mueller A, Cupisti S, Binder H, Hoffmann I, Kiesewetter F, Beckmann MW, et al. Endocrinological markers for assessment of hyperandrogenemia in hirsute women. Horm Res. 2007;67(1):35–41.

    Article  PubMed  CAS  Google Scholar 

  4. Loriaux DL. An approach to the patient with hirsutism. J Clin Endocrinol Metab. 2012;97(9):2957–68.

    Article  PubMed  CAS  Google Scholar 

  5. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453–62.

    Article  PubMed  CAS  Google Scholar 

  6. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2–6.

    Article  PubMed  CAS  Google Scholar 

  7. Chen W, Zouboulis CC, Orfanos CE. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology. 1996;193(3):177–84.

    Article  PubMed  CAS  Google Scholar 

  8. Messenger AG. The control of hair growth: an overview. J Invest Dermatol. 1993;101(1 Suppl):4S–9.

    Article  PubMed  CAS  Google Scholar 

  9. Unluhizarci K, Kaltsas G, Kelestimur F. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Invest. 2012;42(1):86–94.

    Article  PubMed  CAS  Google Scholar 

  10. Speiser PW. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinol Metab Clin North Am. 2001;30(1):31–59. vi.

    Article  PubMed  CAS  Google Scholar 

  11. Trueb RM. Causes and management of hypertrichosis. Am J Clin Dermatol. 2002;3(9):617–27.

    Article  PubMed  Google Scholar 

  12. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–7.

    Article  PubMed  CAS  Google Scholar 

  13. DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab. 2006;91(4):1345–50.

    Article  PubMed  CAS  Google Scholar 

  14. Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(4):1105–20.

    Article  PubMed  CAS  Google Scholar 

  15. Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18(2):146–70.

    Article  PubMed  CAS  Google Scholar 

  16. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88.

    Article  PubMed  Google Scholar 

  17. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245–91.

    Article  PubMed  CAS  Google Scholar 

  18. Raj SG, Raj MH, Talbert LM, Sloan CS, Hicks B. Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome. Obstet Gynecol. 1982;60(1):15–9.

    PubMed  CAS  Google Scholar 

  19. Wiebe RH, Morris CV. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids. Obstet Gynecol. 1984;63(1):12–4.

    PubMed  CAS  Google Scholar 

  20. Guido M, Romualdi D, Giuliani M, Suriano R, Selvaggi L, Apa R, et al. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab. 2004;89(6):2817–23.

    Article  PubMed  CAS  Google Scholar 

  21. Dewis P, Petsos P, Newman M, Anderson DC. The treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol. Clin Endocrinol. 1985;22(1):29–36.

    Article  CAS  Google Scholar 

  22. Cullberg G, Hamberger L, Mattsson LA, Mobacken H, Samsioe G. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome. Acta Obstet Gynecol Scand. 1985;64(3): 195–202.

    Article  PubMed  CAS  Google Scholar 

  23. Darney PD. The androgenicity of progestins. Am J Med. 1995;98(1A):104S–10.

    Article  PubMed  CAS  Google Scholar 

  24. Mathur R, Levin O, Azziz R. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag. 2008;4(2):487–92.

    PubMed  CAS  Google Scholar 

  25. Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, et al. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception. 2013;87(1):93–100.

    Article  PubMed  CAS  Google Scholar 

  26. Cumming DC. Use of spironolactone in treatment of hirsutism. Cleveland Clinic J Med. 1990;57(3):285–7.

    Article  CAS  Google Scholar 

  27. Serafini PC, Catalino J, Lobo RA. The effect of spironolactone on genital skin 5 alpha-reductase activity. J Steroid Biochem. 1985;23(2):191–4.

    Article  PubMed  CAS  Google Scholar 

  28. Brown J, Farquhar C, Lee O, Toomath R, Jepson RG. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev. 2009 (2):CD000194.

    Google Scholar 

  29. Karakurt F, Sahin I, Guler S, Demirbas B, Culha C, Serter R, et al. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study. Adv Ther. 2008;25(4):321–8.

    Article  PubMed  CAS  Google Scholar 

  30. Wong IL, Morris RS, Chang L, Spahn MA, Stanczyk FZ, Lobo RA. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. J Clin Endocrinol Metab. 1995;80(1):233–8.

    Article  PubMed  CAS  Google Scholar 

  31. Brahm J, Brahm M, Segovia R, Latorre R, Zapata R, Poniachik J, et al. Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature. Ann Hepatol. 2011;10(1):93–8.

    PubMed  Google Scholar 

  32. Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane Database Syst Rev. 2003 (4):CD001125.

    Google Scholar 

  33. Azziz R, Ochoa TM, Bradley Jr EL, Potter HD, Boots LR. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. J Clin Endocrinol Metab. 1995;80(12):3406–11.

    Article  PubMed  CAS  Google Scholar 

  34. Falsetti L, Pasinetti E, Ceruti D. Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism. Acta Eur Fertil. 1994;25(5):303–6.

    PubMed  CAS  Google Scholar 

  35. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.

    Article  PubMed  CAS  Google Scholar 

  36. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab. 2001;86(4):1626–32.

    Article  PubMed  CAS  Google Scholar 

  37. Frank-Raue K, Junga G, Raue F, Vecsei P, Ziegler R. Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate. Klin Wochenschr. 1990;68(12):597–601. Therapie des Hirsutismus bei Frauen mit adrenalen Enzymdefekten der Steroidhormonbiosynthese: Vergleich von Dexamethason mit Cyproteronacetat.

    Article  PubMed  CAS  Google Scholar 

  38. Carmina E, Lobo RA. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission. Fertil Steril. 1998;69(6):1075–9.

    Article  PubMed  CAS  Google Scholar 

  39. Hamzavi I, Tan E, Shapiro J, Lui H. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol. 2007;57(1):54–9.

    Article  PubMed  Google Scholar 

  40. Smith SR, Piacquadio DJ, Beger B, Littler C. Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial. Dermatol Surg. 2006;32(10):1237–43.

    Article  PubMed  CAS  Google Scholar 

  41. Olsen EA. Methods of hair removal. J Am Acad Dermatol. 1999;40(2 Pt 1):143–55. quiz 56–7.

    Article  PubMed  CAS  Google Scholar 

  42. McGill DJ, Hutchison C, McKenzie E, McSherry E, Mackay IR. Laser hair removal in women with polycystic ovary syndrome. J Plast Reconstr Aesthet Surg. 2007;60(4):426–31.

    Article  PubMed  CAS  Google Scholar 

  43. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol. 2005;152(5):986–92.

    Article  PubMed  CAS  Google Scholar 

  44. Vachiramon V, Brown T, McMichael AJ. Patient satisfaction and complications following laser hair removal in ethnic skin. J Drugs Dermatol. 2012;11(2):191–5.

    PubMed  Google Scholar 

  45. Hovenic W, DeSpain J. Laser hair reduction and removal. Facial Plastic Surg Clin North Am. 2011;19(2):325–33.

    Article  Google Scholar 

  46. Wagner Jr RF. Physical methods for the management of hirsutism. Cutis. 1990;45(5):319–21. 25-6.

    PubMed  Google Scholar 

  47. Harris K, Ferguson J, Hills S. A comparative study of hair removal at an NHS hospital: luminette intense pulsed light versus electrolysis. J Dermatolog Treat. 2012. Early Online: 1–5.

    Google Scholar 

  48. Chuan SS, Chang RJ. Polycystic ovary syndrome and acne. Skin Therapy Lett. 2010;15(10):1–4.

    PubMed  Google Scholar 

  49. Kelekci KH, Kelekci S, Incki K, Ozdemir O, Yilmaz B. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Int J Dermatol. 2010;49(7):775–9.

    PubMed  Google Scholar 

  50. Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab. 1993;76(2):524–8.

    Article  PubMed  CAS  Google Scholar 

  51. Volpe A, Silferi M, Mauri A, Deiana P, Angioni S, Grasso A, et al. Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. Eur J Obstet Gynecol Reprod Biol. 1994;53(3):205–9.

    Article  PubMed  CAS  Google Scholar 

  52. Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol. 1997;89(4):615–22.

    Article  PubMed  CAS  Google Scholar 

  53. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;7:CD004425.

    Google Scholar 

  54. Koltun W, Maloney JM, Marr J, Kunz M. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 mug plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis. Eur J Obstet Gynecol Reprod Biol. 2011;155(2):171–5.

    Article  PubMed  CAS  Google Scholar 

  55. Thorneycroft H, Gollnick H, Schellschmidt I. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. Cutis. 2004;74(2):123–30.

    PubMed  Google Scholar 

  56. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49 (1 Suppl):S1–37.

    Article  PubMed  Google Scholar 

  57. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56(4):651–63.

    Article  PubMed  Google Scholar 

  58. Del Rosso JQ, Kim G. Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin. 2009;27(1):33–42.

    Article  PubMed  Google Scholar 

  59. Anderson KC, Schwartz MD, Lieu SO. Antibiotics and OC effectiveness. JAAPA. 2013;26(1):11.

    PubMed  Google Scholar 

  60. Yemisci A, Gorgulu A, Piskin S. Effects and side-effects of spironolactone therapy in women with acne. J Eur Acad Dermatol Venereol. 2005;19(2):163–6.

    Article  PubMed  CAS  Google Scholar 

  61. George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutaneous Med Surg. 2008;27(3):188–96.

    Article  CAS  Google Scholar 

  62. Moghetti P, Toscano V. Treatment of hirsutism and acne in hyperandrogenism. Best Pract Res Clin Endocrinol Metab. 2006;20(2):221–34.

    Article  PubMed  CAS  Google Scholar 

  63. Zeichner JA. Optimizing topical combination therapy for the treatment of acne vulgaris. J Drugs Dermatol. 2012;11(3):313–7.

    PubMed  CAS  Google Scholar 

  64. Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, et al. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris. J Drugs Dermatol. 2011;10(7):783–92.

    PubMed  CAS  Google Scholar 

  65. Camacho-Martinez FM. Hair loss in women. Semin Cutaneous Med Surg. 2009;28(1):19–32.

    Article  CAS  Google Scholar 

  66. Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol. 2001;144(2):297–304.

    Article  PubMed  CAS  Google Scholar 

  67. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341(7):491–7.

    Article  PubMed  CAS  Google Scholar 

  68. Chartier MB, Hoss DM, Grant-Kels JM. Approach to the adult female patient with diffuse nonscarring alopecia. J Am Acad Dermatol. 2002;47(6):809–18. quiz 18–20.

    Article  PubMed  Google Scholar 

  69. Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias. J Am Acad Dermatol. 2005;53(1):1–37. quiz 8–40.

    Article  PubMed  Google Scholar 

  70. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97(3):247–54.

    Article  PubMed  CAS  Google Scholar 

  71. Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130–6.

    Article  PubMed  CAS  Google Scholar 

  72. Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol. 1993;32(10):758–62.

    Article  PubMed  CAS  Google Scholar 

  73. DeVillez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol. 1994;130(3):303–7.

    Article  PubMed  CAS  Google Scholar 

  74. Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541–53.

    Article  PubMed  Google Scholar 

  75. Shum KW, Cullen DR, Messenger AG. Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol. 2002;47(5):733–9.

    Article  PubMed  Google Scholar 

  76. Iorizzo M, Vincenzi C, Voudouris S, Piraccini BM, Tosti A. Finasteride treatment of female pattern hair loss. Arch Dermatol. 2006;142(3):298–302.

    Article  PubMed  CAS  Google Scholar 

  77. Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril. 2003;79(1):91–5.

    Article  PubMed  Google Scholar 

  78. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466–73.

    Article  PubMed  CAS  Google Scholar 

  79. Desai S, Mahmoud BH, Bhatia AC, Hamzavi IH. Paradoxical hypertrichosis after laser therapy: a review. Dermatol Surg. 2010;36(3):291–8.

    Article  PubMed  CAS  Google Scholar 

  80. Rangwala S, Rashid RM. Alopecia: a review of laser and light therapies. Dermatol Online J. 2012;18(2):3.

    PubMed  Google Scholar 

  81. Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008;59(4):547–66. quiz 67–8.

    Article  PubMed  Google Scholar 

  82. Avram M, Rogers N. Contemporary hair transplantation. Dermatol Surg. 2009;35(11):1705–19.

    Article  PubMed  CAS  Google Scholar 

  83. Caroli S, Pathomvanich D, Amonpattana K, Kumar A. Current status of hair restoration surgery. Int Surg. 2011;96(4):345–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology and Womens Health, Montefiore’s Institute for Reproductive Medicine and Health, Montefiore Medical Center, 1300 Morris Park Avenue, Mazer 621, Bronx, NY, 10461, USA

    Beth McAvey M.D. & Harry Lieman M.D.

Authors
  1. Beth McAvey M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harry Lieman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harry Lieman M.D. .

Editor information

Editors and Affiliations

  1. Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine Program for Polycystic Ovary Syndrome Yale Reproductive Endocrinology, New Haven, Connecticut, USA

    Lubna Pal

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

McAvey, B., Lieman, H. (2014). Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss. In: Pal, L. (eds) Polycystic Ovary Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8394-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8394-6_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8393-9

  • Online ISBN: 978-1-4614-8394-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation